Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritis.

Esther Beckers Annelies Boonen Astrid van Tubergen

Published in: RMD open (2023)

We developed an evidence-based decision aid to support axSpA patients who face a treatment decision to initiate or switch a b/tsDMARD and introduced this in clinical practice.

Keyphrases

clinical practice
decision making
rheumatoid arthritis
ankylosing spondylitis
cancer therapy
drug delivery
rheumatoid arthritis patients
drug induced
combination therapy
replacement therapy